SUDEEPPHRM

Sudeep Pharma Share Price

 

 

Invest in Sudeep Pharma with 2.74X leverage

Invest with MTF

Performance

  • Low
  • ₹580
  • High
  • ₹610
  • 52 Week Low
  • ₹544
  • 52 Week High
  • ₹795
  • Open Price₹603
  • Previous Close₹611
  • Volume170,996
  • 50 DMA-
  • 100 DMA-
  • 200 DMA-

Investment Returns

  • Over 1 Month -13.01%
  • Over 3 Month -1.1%
  • Over 6 Month -1.1%
  • Over 1 Year -1.1%

Smart Investing Starts Here Start SIP with Sudeep Pharma for Steady Growth!

Invest Now

Sudeep Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -
  • PEG Ratio
  • -
  • Market Cap Cr
  • 6,624
  • P/B Ratio
  • 9.1
  • Average True Range
  • 29.48
  • EPS
  • 12.29
  • Dividend Yield
  • 0
  • MACD Signal
  • -31.05
  • RSI
  • 36.32
  • MFI
  • 54.81

Sudeep Pharma Financials

Sudeep Pharma Technicals

EMA & SMA

Current Price
₹586.45
-24.85 (-4.07%)
pointer
  • Bearish Moving Average 9
  • Bullish Moving Average 0
  • 20 Day
  • ₹614.61
  • 50 Day
  • -
  • 100 Day
  • -
  • 200 Day
  • -

Resistance and Support

592.07 Pivot Speed
  • R3 633.88
  • R2 621.82
  • R1 604.13
  • S1 574.38
  • S2 562.32
  • S3 544.63

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

N/A

Group Rank

Sudeep Pharma manufactures ingredient solutions for pharmaceutical, nutraceutical, and food industries. Its products support human health and nutrition and are supplied to global markets. The company focuses on quality-driven manufacturing for use in medicines, supplements, and food formulations.

Sudeep Pharma Ltd has an operating revenue of Rs. 1,248.86 Cr. on a trailing 12-month basis. An annual revenue growth of 10% is good, Pre-tax margin of 36% is great, ROE of 28% is exceptional. The company has a reasonable debt to equity of 8%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 82 which is a GOOD score indicating consistency in earnings, a RS Rating of 27 which is POOR indicating the underperformance as compared to other stocks, Group Rank of 112 indicates it belongs to a poor industry group of Chemicals-Specialty and a Master Score of D is close to being the worst. Overall, the stock has great fundamentals and technical strength to stay in momentum.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Sudeep Pharma Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-12-19 Quarterly Results

Sudeep Pharma F&O

Sudeep Pharma Shareholding Pattern

76.15%
5.67%
1.06%
1.67%
3.27%
12.18%

Sudeep Pharma FAQs

Sudeep Pharma share price is ₹586 As on 19 January, 2026 | 07:50

The Market Cap of Sudeep Pharma is ₹6623.9 Cr As on 19 January, 2026 | 07:50

The P/E ratio of Sudeep Pharma is As on 19 January, 2026 | 07:50

The PB ratio of Sudeep Pharma is 9.1 As on 19 January, 2026 | 07:50

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23